Clinical Trials Browser

Phase 2 × Gastric Cancer Peritoneal Metastases × Clear all

NCT07304258 2025-12-26

A Prospective, Phase II Clinical Study of HIPEC Combined With NIPS and Tislelizumab Conversion Therapy for Gastric Cancer With Peritoneal Metastasis With Positive Cytology Alone or PCI Score ≤10

Phase 2 Not yet recruiting

Gastrointestinal

Gastric Cancer Peritoneal Metastases

NCT06487715 2024-07-05

Safety and Efficacy of Systemic Chemotherapy Plus PD-1 Inhibitor in Combination With Bevacizumab in Gastric Cancer With Peritoneal Metastasis

Phase 2 Enrolling by invitation

Gastrointestinal

Gastric Cancer Peritoneal Metastases